Article Details

FDA grants approval to Ebola drug from Ridgeback

Retrieved on: 2020-12-22 16:41:15

Tags for this article:

Click the tags to see associated articles and topics

FDA grants approval to Ebola drug from Ridgeback. View article details on hiswai:

Excerpt

Ebanga is a single human monoclonal antibody, while the Regeneron treatment employs three synthetic antibodies against the Ebola virus.

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up